Edition:
United Kingdom

Transgene SA (TRNG.PA)

TRNG.PA on Paris Stock Exchange

2.76EUR
19 Feb 2019
Change (% chg)

-- (--)
Prev Close
€2.76
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
39,204
52-wk High
€3.31
52-wk Low
€2.57

Chart for

About

Transgene SA is a biopharmaceutical company. The Company designs and develops immunotherapy products to treat cancer and infectious diseases. These products use viral vectors to directly or indirectly destroy diseased cells. The Company has approximately three products in clinical development: two immunotherapy products for... (more)

Overall

Beta: -0.15
Market Cap(Mil.): €186.79
Shares Outstanding(Mil.): 56.43
Dividend: --
Yield (%): --

Financials

  TRNG.PA Industry Sector
P/E (TTM): -- 69.44 33.70
EPS (TTM): -0.50 -- --
ROI: -39.20 8.92 14.45
ROE: -143.68 10.08 15.96

Earnings vs. Estimates